Evidence map›Paper›PMID 29052075›Full record

ArticleMetabolic brain disease2018

Dopamine D

Alberto Avila-Luna, Arturo Gálvez-Rosas, Alfredo Durand-Rivera, Laura-Elisa Ramos-Languren, Camilo Ríos, José-Antonio Arias-Montaño, Antonio Bueno-Nava

Abstract read
PubMed Publisher
In one paragraph

Article in Metabolic brain disease, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
0.6field-weighted citation impact, top 38% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 17 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Targeting the dopamine DBritish journal of pharmacology · 2018
    Article
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 1 country.

Alberto Avila-LunaDivisión de Neurociencias, Instituto Nacional de Rehabilitación Luis Guillermo Ibarra Ibarra, SSa, Calz México-Xochimilco 289, 14389, Ciudad de México, Mexico.
Arturo Gálvez-RosasDivisión de Neurociencias, Instituto Nacional de Rehabilitación Luis Guillermo Ibarra Ibarra, SSa, Calz México-Xochimilco 289, 14389, Ciudad de México, Mexico.
Alfredo Durand-RiveraDivisión de Neurociencias, Instituto Nacional de Rehabilitación Luis Guillermo Ibarra Ibarra, SSa, Calz México-Xochimilco 289, 14389, Ciudad de México, Mexico.
Laura-Elisa Ramos-LangurenDepartamento de Neuroquímica, Instituto Nacional de Neurología y Neurocirugía Manuel Velasco Suárez, SSa, Insurgentes Sur 3877, 14269, Ciudad de México, Mexico.
Camilo RíosDepartamento de Neuroquímica, Instituto Nacional de Neurología y Neurocirugía Manuel Velasco Suárez, SSa, Insurgentes Sur 3877, 14269, Ciudad de México, Mexico.
José-Antonio Arias-MontañoDepartamento de Fisiología, Biofísica y Neurociencias, Centro de Investigación y de Estudios Avanzados del IPN, Av. IPN 2508, 07360, Ciudad de México, Mexico.
Antonio Bueno-NavaDivisión de Neurociencias, Instituto Nacional de Rehabilitación Luis Guillermo Ibarra Ibarra, SSa, Calz México-Xochimilco 289, 14389, Ciudad de México, Mexico. abueno@inr.gob.mx.
Instituto Nacional de Rehabilitación · MXInstituto Nacional de Neurología y Neurocirugía · MXCenter for Research and Advanced Studies of the National Polytechnic Institute · MX

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Dopamine (DA) modulates motor coordination, and its depletion, as in Parkinson's disease, produces motor impairment. The basal ganglia, cerebellum and cerebral cortex are interconnected, have functional roles in motor coordination, and possess dopamine D

Indexed as

2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepineAnimalsBenzazepinesCorpus StriatumDopamine AgonistsMaleMotor ActivityParkinson DiseasePostural BalanceReceptors, Dopamine D1Receptors, Dopamine D22,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepineBenzazepinesDopamine AgonistsReceptors, Dopamine D1Receptors, Dopamine D2SCH 23390SK&F 82958D1 receptorDopamineMotor coordinationStriatum

Identifiers

PMID29052075
OpenAlexW2766720491

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.